What is SeattleNTC?
SeattleNTC operates as a prominent mental health clinic, distinguished by its specialization in advanced therapeutic interventions. The clinic offers cutting-edge treatments including Transcranial Magnetic Stimulation (TMS), ketamine therapy, Electroconvulsive Therapy (ECT), and Vagus Nerve Stimulation (VNS). These services are primarily directed at managing complex conditions such as treatment-resistant depression, Post-Traumatic Stress Disorder (PTSD), and bipolar disorder. SeattleNTC is recognized for its expert approach to intricate mental health challenges, providing a suite of interventional psychiatric options for patients who may not have found relief through conventional methods. With a network of facilities across Washington and a dedicated team of highly skilled professionals, the organization is committed to delivering superior mental health care.
How much funding has SeattleNTC raised?
SeattleNTC has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in SeattleNTC
PPP
Public-Private Partnership
What's next for SeattleNTC?
The substantial capital infusion, contextualized as a large-scale late-stage funding event, signals SeattleNTC's readiness for significant scaling and market penetration. This strategic investment is likely to fuel the expansion of its service offerings, potentially through the establishment of new clinic locations or the enhancement of existing treatment modalities. Furthermore, the backing may support advancements in research and development, solidifying SeattleNTC's role as an innovator in interventional psychiatry. The company's focus on complex mental health issues positions it to capitalize on growing demand for specialized and effective therapeutic solutions.
See full SeattleNTC company page
